| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tumor Suppressor Protein p53 | 19 | 2023 | 3623 | 2.240 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 9 | 2022 | 518 | 1.930 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2017 | 2560 | 0.860 |
Why?
|
| Ubiquitin-Protein Ligases | 4 | 2022 | 867 | 0.790 |
Why?
|
| Radiation, Ionizing | 2 | 2019 | 191 | 0.750 |
Why?
|
| Fibroblasts | 2 | 2022 | 1693 | 0.570 |
Why?
|
| RNA, Untranslated | 7 | 2012 | 244 | 0.560 |
Why?
|
| Gastrointestinal Tract | 1 | 2019 | 326 | 0.550 |
Why?
|
| Feedback, Physiological | 2 | 2014 | 196 | 0.540 |
Why?
|
| Insulin-Like Growth Factor II | 5 | 2012 | 110 | 0.490 |
Why?
|
| Genomic Imprinting | 6 | 2012 | 195 | 0.480 |
Why?
|
| Gastrointestinal Diseases | 1 | 2019 | 597 | 0.480 |
Why?
|
| Mice | 26 | 2023 | 35331 | 0.430 |
Why?
|
| Nuclear Proteins | 4 | 2018 | 3385 | 0.430 |
Why?
|
| Ubiquitin | 1 | 2014 | 342 | 0.420 |
Why?
|
| Longevity | 1 | 2013 | 154 | 0.410 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2022 | 2397 | 0.400 |
Why?
|
| Radiation Injuries | 1 | 2019 | 1449 | 0.400 |
Why?
|
| DNA-Binding Proteins | 8 | 2006 | 4911 | 0.390 |
Why?
|
| Repressor Proteins | 6 | 2012 | 1699 | 0.390 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2014 | 593 | 0.390 |
Why?
|
| Hematologic Diseases | 1 | 2012 | 246 | 0.380 |
Why?
|
| Protein Multimerization | 1 | 2011 | 243 | 0.360 |
Why?
|
| DNA Damage | 4 | 2014 | 1989 | 0.350 |
Why?
|
| Models, Animal | 1 | 2012 | 691 | 0.340 |
Why?
|
| Transcriptional Activation | 5 | 2023 | 1096 | 0.340 |
Why?
|
| Hematopoiesis | 1 | 2012 | 573 | 0.330 |
Why?
|
| Embryonic Development | 1 | 2011 | 319 | 0.320 |
Why?
|
| Gene Expression | 1 | 2017 | 3594 | 0.320 |
Why?
|
| Animals | 30 | 2023 | 61014 | 0.320 |
Why?
|
| Li-Fraumeni Syndrome | 2 | 2023 | 165 | 0.310 |
Why?
|
| Ribonuclease III | 2 | 2019 | 186 | 0.300 |
Why?
|
| Gene Expression Regulation | 6 | 2014 | 4071 | 0.290 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2019 | 260 | 0.290 |
Why?
|
| Mutation | 9 | 2022 | 15642 | 0.260 |
Why?
|
| Transcription Factors | 5 | 2014 | 5362 | 0.260 |
Why?
|
| Carcinogenesis | 4 | 2022 | 1049 | 0.250 |
Why?
|
| Cell Cycle Proteins | 3 | 2017 | 2100 | 0.250 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 1514 | 0.250 |
Why?
|
| Protein Binding | 4 | 2022 | 3483 | 0.240 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2004 | 220 | 0.220 |
Why?
|
| Protein Stability | 2 | 2014 | 374 | 0.210 |
Why?
|
| Mice, Transgenic | 7 | 2018 | 4245 | 0.210 |
Why?
|
| Radiation Tolerance | 3 | 2018 | 635 | 0.210 |
Why?
|
| Geminiviridae | 1 | 2001 | 1 | 0.200 |
Why?
|
| Plants, Medicinal | 1 | 2001 | 47 | 0.200 |
Why?
|
| Fabaceae | 1 | 2001 | 29 | 0.190 |
Why?
|
| Osteosarcoma | 2 | 2022 | 950 | 0.190 |
Why?
|
| Promoter Regions, Genetic | 7 | 2014 | 3109 | 0.190 |
Why?
|
| Organ Specificity | 1 | 2023 | 704 | 0.190 |
Why?
|
| Signal Transduction | 5 | 2019 | 12151 | 0.190 |
Why?
|
| Neoplasms, Experimental | 2 | 2018 | 749 | 0.190 |
Why?
|
| Gain of Function Mutation | 1 | 2022 | 134 | 0.190 |
Why?
|
| CCCTC-Binding Factor | 6 | 2012 | 34 | 0.190 |
Why?
|
| Carrier Proteins | 2 | 2018 | 2055 | 0.180 |
Why?
|
| Ubiquitination | 2 | 2014 | 579 | 0.180 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2019 | 84 | 0.170 |
Why?
|
| Disease Models, Animal | 5 | 2019 | 7429 | 0.160 |
Why?
|
| DNA Helicases | 1 | 2001 | 451 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2018 | 9067 | 0.160 |
Why?
|
| Models, Biological | 3 | 2019 | 3255 | 0.160 |
Why?
|
| Cell Line, Tumor | 6 | 2022 | 14855 | 0.150 |
Why?
|
| Gene Knock-In Techniques | 2 | 2018 | 178 | 0.150 |
Why?
|
| Retinoids | 1 | 2018 | 171 | 0.150 |
Why?
|
| Cloning, Molecular | 4 | 2006 | 1226 | 0.140 |
Why?
|
| Mice, Knockout | 5 | 2019 | 5804 | 0.140 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2018 | 229 | 0.140 |
Why?
|
| Homozygote | 1 | 2018 | 751 | 0.140 |
Why?
|
| Trans-Activators | 2 | 2006 | 1624 | 0.130 |
Why?
|
| Mutation, Missense | 2 | 2018 | 1219 | 0.130 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2013 | 1288 | 0.130 |
Why?
|
| Doxorubicin | 2 | 2014 | 3059 | 0.130 |
Why?
|
| RNA, Long Noncoding | 7 | 2012 | 612 | 0.130 |
Why?
|
| Apoptosis | 4 | 2019 | 7759 | 0.130 |
Why?
|
| Lymphoma | 2 | 2017 | 1502 | 0.130 |
Why?
|
| ras Proteins | 1 | 2019 | 783 | 0.130 |
Why?
|
| RNA Splicing | 1 | 2017 | 375 | 0.120 |
Why?
|
| Chromatin | 3 | 2012 | 972 | 0.120 |
Why?
|
| Phospholipases A2, Calcium-Independent | 1 | 2014 | 20 | 0.120 |
Why?
|
| Genotype | 2 | 2014 | 4168 | 0.120 |
Why?
|
| Cycloheximide | 1 | 2014 | 99 | 0.120 |
Why?
|
| Leupeptins | 1 | 2014 | 69 | 0.120 |
Why?
|
| Dactinomycin | 1 | 2014 | 145 | 0.120 |
Why?
|
| Tamoxifen | 1 | 2018 | 884 | 0.110 |
Why?
|
| Protein Denaturation | 1 | 2013 | 71 | 0.110 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2014 | 187 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 5 | 2019 | 7173 | 0.110 |
Why?
|
| Fatty Liver | 1 | 2014 | 252 | 0.100 |
Why?
|
| Aging | 2 | 2018 | 1578 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 1293 | 0.100 |
Why?
|
| Proteolysis | 1 | 2014 | 376 | 0.100 |
Why?
|
| RNA, Neoplasm | 1 | 2014 | 797 | 0.100 |
Why?
|
| Neuroendocrine Tumors | 1 | 2018 | 649 | 0.100 |
Why?
|
| Cesium Radioisotopes | 1 | 2011 | 39 | 0.100 |
Why?
|
| Blotting, Southern | 1 | 2011 | 404 | 0.090 |
Why?
|
| Ultraviolet Rays | 1 | 2013 | 590 | 0.090 |
Why?
|
| Point Mutation | 1 | 2014 | 781 | 0.090 |
Why?
|
| DNA Primers | 2 | 2011 | 1422 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2014 | 501 | 0.090 |
Why?
|
| Lipids | 1 | 2014 | 661 | 0.090 |
Why?
|
| Chromosome Aberrations | 1 | 2017 | 1982 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2014 | 5670 | 0.090 |
Why?
|
| E2F5 Transcription Factor | 2 | 1999 | 8 | 0.080 |
Why?
|
| Transcription Factor DP1 | 2 | 1999 | 55 | 0.080 |
Why?
|
| E2F4 Transcription Factor | 2 | 1999 | 29 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2017 | 4646 | 0.080 |
Why?
|
| Learning | 1 | 2012 | 421 | 0.080 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2012 | 505 | 0.080 |
Why?
|
| Genes, Reporter | 3 | 2002 | 811 | 0.080 |
Why?
|
| DNA Methylation | 5 | 2012 | 2736 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 3666 | 0.080 |
Why?
|
| Humans | 18 | 2019 | 270843 | 0.080 |
Why?
|
| Bone Neoplasms | 2 | 2022 | 2652 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 1878 | 0.070 |
Why?
|
| Phosphorylation | 3 | 2019 | 4887 | 0.070 |
Why?
|
| Tumor Burden | 1 | 2012 | 2019 | 0.070 |
Why?
|
| Sarcoma | 1 | 2017 | 1830 | 0.070 |
Why?
|
| Chromosomes | 1 | 2006 | 251 | 0.070 |
Why?
|
| Biomarkers | 1 | 2017 | 5176 | 0.060 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 2589 | 0.060 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 2004 | 10 | 0.060 |
Why?
|
| Molecular Sequence Data | 3 | 2001 | 6127 | 0.060 |
Why?
|
| Alleles | 3 | 2018 | 2488 | 0.060 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 2 | 2002 | 118 | 0.060 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2023 | 25 | 0.060 |
Why?
|
| Methylation | 1 | 2004 | 599 | 0.050 |
Why?
|
| Epigenesis, Genetic | 2 | 2006 | 1432 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2014 | 2158 | 0.050 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2001 | 58 | 0.050 |
Why?
|
| CpG Islands | 1 | 2004 | 655 | 0.050 |
Why?
|
| Binding Sites | 4 | 2012 | 2210 | 0.050 |
Why?
|
| Leukemia | 1 | 2010 | 1657 | 0.050 |
Why?
|
| Genome, Viral | 1 | 2001 | 167 | 0.050 |
Why?
|
| Cell Death | 1 | 2023 | 675 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 5235 | 0.050 |
Why?
|
| Protein Folding | 1 | 2001 | 292 | 0.050 |
Why?
|
| Chloroplasts | 1 | 2000 | 12 | 0.050 |
Why?
|
| Female | 9 | 2018 | 147292 | 0.040 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 1999 | 52 | 0.040 |
Why?
|
| E2F2 Transcription Factor | 1 | 1999 | 25 | 0.040 |
Why?
|
| E2F3 Transcription Factor | 1 | 1999 | 23 | 0.040 |
Why?
|
| Male | 7 | 2018 | 127630 | 0.040 |
Why?
|
| E2F Transcription Factors | 1 | 1999 | 131 | 0.040 |
Why?
|
| Two-Hybrid System Techniques | 1 | 1999 | 182 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2001 | 580 | 0.040 |
Why?
|
| Neoplasms | 2 | 2019 | 15710 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2002 | 840 | 0.040 |
Why?
|
| E2F1 Transcription Factor | 1 | 1999 | 197 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 4062 | 0.040 |
Why?
|
| Histone Chaperones | 1 | 2018 | 32 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2001 | 1271 | 0.040 |
Why?
|
| X-linked Nuclear Protein | 1 | 2018 | 59 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 1998 | 73 | 0.040 |
Why?
|
| Base Sequence | 2 | 2001 | 4932 | 0.040 |
Why?
|
| Co-Repressor Proteins | 1 | 2018 | 120 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 1998 | 336 | 0.040 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2018 | 132 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2000 | 516 | 0.040 |
Why?
|
| Liver | 3 | 2014 | 2990 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 2018 | 524 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 1998 | 698 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 258 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2018 | 270 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2018 | 661 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 322 | 0.040 |
Why?
|
| Transfection | 2 | 2002 | 2989 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2000 | 567 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 16053 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2002 | 5511 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 1998 | 847 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2001 | 2943 | 0.030 |
Why?
|
| Disease Progression | 2 | 2019 | 6891 | 0.030 |
Why?
|
| Loss of Heterozygosity | 1 | 2017 | 624 | 0.030 |
Why?
|
| Histones | 2 | 2018 | 1493 | 0.030 |
Why?
|
| Transgenes | 1 | 2017 | 573 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 886 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2010 | 6224 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2018 | 1337 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 1513 | 0.030 |
Why?
|
| Response Elements | 1 | 2014 | 197 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2000 | 1049 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2000 | 1223 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2014 | 3238 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2014 | 639 | 0.030 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 848 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 1589 | 0.030 |
Why?
|
| Wnt1 Protein | 1 | 2012 | 101 | 0.030 |
Why?
|
| Chromosomes, Mammalian | 1 | 2012 | 61 | 0.030 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2012 | 122 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2012 | 245 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 2403 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 4281 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2012 | 167 | 0.020 |
Why?
|
| Aged | 1 | 2017 | 72902 | 0.020 |
Why?
|
| Plicamycin | 1 | 2010 | 30 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 512 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 532 | 0.020 |
Why?
|
| Chickens | 1 | 2010 | 527 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2012 | 965 | 0.020 |
Why?
|
| Middle Aged | 1 | 2017 | 89535 | 0.020 |
Why?
|
| Sp1 Transcription Factor | 1 | 2010 | 190 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2011 | 485 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 2520 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2011 | 491 | 0.020 |
Why?
|
| Transcriptome | 1 | 2018 | 1952 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2012 | 734 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 5239 | 0.020 |
Why?
|
| DNA Replication | 1 | 2012 | 753 | 0.020 |
Why?
|
| RNA Interference | 1 | 2012 | 1411 | 0.020 |
Why?
|
| Actins | 1 | 2010 | 615 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2010 | 1182 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2010 | 1653 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2010 | 5716 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2011 | 1005 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 3596 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 2114 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2010 | 1123 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2006 | 284 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2011 | 2480 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2004 | 3148 | 0.010 |
Why?
|
| Embryonic Stem Cells | 1 | 2006 | 306 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 5295 | 0.010 |
Why?
|
| Cytokines | 1 | 2012 | 2871 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2006 | 1350 | 0.010 |
Why?
|
| Choriocarcinoma | 1 | 2002 | 49 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2004 | 802 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 2000 | 131 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 2000 | 95 | 0.010 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2000 | 73 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2000 | 154 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2000 | 214 | 0.010 |
Why?
|
| Hydroxamic Acids | 1 | 2002 | 444 | 0.010 |
Why?
|
| Light | 1 | 2000 | 267 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2000 | 620 | 0.010 |
Why?
|
| Luciferases | 1 | 2000 | 454 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2000 | 882 | 0.010 |
Why?
|
| Temperature | 1 | 2000 | 522 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2000 | 472 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 13266 | 0.010 |
Why?
|
| Uterine Neoplasms | 1 | 2002 | 566 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2000 | 915 | 0.010 |
Why?
|
| Antifungal Agents | 1 | 2002 | 854 | 0.010 |
Why?
|
| Calcium | 1 | 2000 | 1558 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 22249 | 0.010 |
Why?
|
| DNA | 1 | 2000 | 2745 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 34238 | 0.010 |
Why?
|
| Pregnancy | 1 | 2002 | 7825 | 0.000 |
Why?
|